Fuller & Thaler Asset Management
COLL icon

Fuller & Thaler Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Fuller & Thaler Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.1M Buy
1,632,781
+133,197
+9% +$4.55M 0.16% 205
2026
Q1 		$49.6M Sell
1,499,584
-488
-0% -$20.7K 0.17% 195
2025
Q4 		$69.5M Sell
1,500,072
-2,602
-0.2% -$109K 0.23% 162
2025
Q3 		$52.6M Buy
1,502,674
+71,645
+5% +$2.49M 0.18% 190
2025
Q2 		$42.3M Buy
1,431,029
+59,581
+4% +$1.7M 0.15% 206
2025
Q1 		$40.9M Buy
1,371,448
+19,568
+1% +$598K 0.16% 203
2024
Q4 		$38.7M Sell
1,351,880
-18,074
-1% -$598K 0.15% 212
2024
Q3 		$52.9M Buy
1,369,954
+178,581
+15% +$6.37M 0.21% 154
2024
Q2 		$38.4M Buy
1,191,373
+222,174
+23% +$7.7M 0.16% 184
2024
Q1 		$37.6M Buy
+969,199
New +$33.9M 0.16% 169

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Fuller & Thaler Asset Management's COLL Position: Q2 2026 in Review

Fuller & Thaler Asset Management increased its Collegium Pharmaceutical (COLL) stake by 8.9% in Q2 2026, buying an estimated $4.55M and bringing the position to 1,632,781 shares worth $59.1M. The position accounts for 0.16% of the portfolio, ranked #205.

Fuller & Thaler Asset Management first reported a position in COLL in Q1 2024 and has held it in 10 quarters since. The position peaked at $69.5M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Fuller & Thaler Asset Management held 1,632,781 shares of Collegium Pharmaceutical worth $59.1M as of Q2 2026.
  • Fuller & Thaler Asset Management bought 133,197 Collegium Pharmaceutical shares in Q2 2026, an estimated $4.55M.
  • Collegium Pharmaceutical made up 0.16% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #205 holding.
  • Fuller & Thaler Asset Management first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • Fuller & Thaler Asset Management's Collegium Pharmaceutical position peaked at $69.5M in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.